Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates.May 2026 sharpened a new imbalance in global cannabis: profitability is finally arriving, while access is tightening at the point of care. In the United States, DEA's Schedule III registration portal...
Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates.April 2026 saw global cannabis splitting into two reform tracks running in opposite directions. The United States moved medical cannabis to Schedule III, unlocking §280E relief across a market estimated near US$47bn —...
Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates. March delivered the clearest evidence yet that the global cannabis industry is maturing faster than the regulatory frameworks governing it. Record earnings seasons in Canada and Germany coincided with deepening price compression...
Access the full version of this brief with detailed access to the complete recap of over 300 global updates in the last month, as well as a curated database of +7,000 regulation updates, market reports and science papers. February 2026 was defined by cross-border consolidation on an unprecedented scale. Organigram acquired Sanity Group for €227M — Europe's largest cannabis deal — as Germany crossed 201 tonnes...
